Fulgent Genetics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fulgent Genetics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Fulgent Genetics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $9.19M, a 34.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $9.19M -$4.87M -34.7% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $9.23M -$4M -30.3% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $10.8M -$3.95M -26.7% Dec 31, 2023 10-Q 2024-08-02
Q3 2023 $12.4M -$3.96M -24.2% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $14.1M -$3.98M -22% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $13.2M +$6.56M +98.5% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $14.8M +$7.64M +107% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $16.4M +$8.86M +118% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $18M +$15.9M +729% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $6.66M +$5.74M +618% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $7.14M +$6.31M +762% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $7.5M +$4.82M +180% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $2.18M -$630K -22.5% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $928K -$1.6M -63.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $828K -$1.81M -68.6% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $2.68M -$59K -2.15% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $2.81M +$50K +1.81% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $2.53M -$333K -11.7% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $2.63M -$367K -12.2% Dec 31, 2019 10-K 2021-03-08
Q3 2019 $2.74M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $2.76M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $2.86M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $3M Jan 1, 2019 10-K 2021-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.